Form 4 for IMMX Immix Biopharma, Inc.
Accepted 2021-12-20 00:00:00 ET · period of report 2021-12-20 · accession 0001493152-21-032036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-12-20 | 2021-12-17+ | IMMX | Torchilin Vladimir P | Scientific Co-Founder | P - Purchase | $4.78 | +5,200 | 902.2K | +0.6% | +$24.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-20 | P | A | 3,000 | $5.00 | 905,200 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-17 | P | A | 2,200 | $4.47 | 902,200 | D | — | — |